A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia

Background and Aims: To examine characteristics of first-time methadone and buprenorphine clients and factors associated with risk of leaving first treatment in New South Wales (NSW), Australia. Design: Retrospective linkage study of opioid substitution therapy (OST) treatment, court, custody and mo...

Full description

Bibliographic Details
Main Authors: Burns, L., Gisev, N., Larney, S., Dobbins, T., Gibson, A., Kimber, J., Larance, B., Mattick, R., Butler, Tony, Degenhardt, L.
Format: Journal Article
Published: 2015
Online Access:http://hdl.handle.net/20.500.11937/28267
_version_ 1848752489734602752
author Burns, L.
Gisev, N.
Larney, S.
Dobbins, T.
Gibson, A.
Kimber, J.
Larance, B.
Mattick, R.
Butler, Tony
Degenhardt, L.
author_facet Burns, L.
Gisev, N.
Larney, S.
Dobbins, T.
Gibson, A.
Kimber, J.
Larance, B.
Mattick, R.
Butler, Tony
Degenhardt, L.
author_sort Burns, L.
building Curtin Institutional Repository
collection Online Access
description Background and Aims: To examine characteristics of first-time methadone and buprenorphine clients and factors associated with risk of leaving first treatment in New South Wales (NSW), Australia. Design: Retrospective linkage study of opioid substitution therapy (OST) treatment, court, custody and mortality data. Setting: NSW, Australia. Participants: First-time OST entrants (August 2001–December 2010). Measurements: Characteristics of clients were examined. Time-dependent Cox models examined factors associated with the risk of leaving first treatment, with demographic, criminographic and treatment variables jointly considered. Interactions between medication and other variables upon risk of leaving treatment were examined.Findings: There were 15 600 treatment entrants: 7183 (46%) commenced buprenorphine, 8417 (54%) commenced methadone; the proportion entering buprenorphine increased over time. Those starting buprenorphine switched medications more frequently and had more subsequent treatment episodes. Buprenorphine retention was also poorer. On average, 44% spent 3+ months in treatment compared with 70% of those commencing methadone; however, buprenorphine retention for first-time entrants improved over time, whereas methadone retention did not. Multivariable Cox models indicated that in addition to sex, age, treatment setting and criminographic variables, the risk of leaving a first treatment episode was greater on any given day for those receiving buprenorphine, and was dependent on the year treatment was initiated. There was no interaction between any demographic variables and medication received, suggesting no clear evidence of any particular groups for whom each medication might be better suited in terms of improving retention. Conclusions: Although retention rates for buprenorphine treatment have improved in New South Wales, Australia, individuals starting methadone treatment still show higher retention rates.
first_indexed 2025-11-14T08:09:26Z
format Journal Article
id curtin-20.500.11937-28267
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T08:09:26Z
publishDate 2015
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-282672017-09-13T15:20:00Z A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia Burns, L. Gisev, N. Larney, S. Dobbins, T. Gibson, A. Kimber, J. Larance, B. Mattick, R. Butler, Tony Degenhardt, L. Background and Aims: To examine characteristics of first-time methadone and buprenorphine clients and factors associated with risk of leaving first treatment in New South Wales (NSW), Australia. Design: Retrospective linkage study of opioid substitution therapy (OST) treatment, court, custody and mortality data. Setting: NSW, Australia. Participants: First-time OST entrants (August 2001–December 2010). Measurements: Characteristics of clients were examined. Time-dependent Cox models examined factors associated with the risk of leaving first treatment, with demographic, criminographic and treatment variables jointly considered. Interactions between medication and other variables upon risk of leaving treatment were examined.Findings: There were 15 600 treatment entrants: 7183 (46%) commenced buprenorphine, 8417 (54%) commenced methadone; the proportion entering buprenorphine increased over time. Those starting buprenorphine switched medications more frequently and had more subsequent treatment episodes. Buprenorphine retention was also poorer. On average, 44% spent 3+ months in treatment compared with 70% of those commencing methadone; however, buprenorphine retention for first-time entrants improved over time, whereas methadone retention did not. Multivariable Cox models indicated that in addition to sex, age, treatment setting and criminographic variables, the risk of leaving a first treatment episode was greater on any given day for those receiving buprenorphine, and was dependent on the year treatment was initiated. There was no interaction between any demographic variables and medication received, suggesting no clear evidence of any particular groups for whom each medication might be better suited in terms of improving retention. Conclusions: Although retention rates for buprenorphine treatment have improved in New South Wales, Australia, individuals starting methadone treatment still show higher retention rates. 2015 Journal Article http://hdl.handle.net/20.500.11937/28267 10.1111/add.12834 restricted
spellingShingle Burns, L.
Gisev, N.
Larney, S.
Dobbins, T.
Gibson, A.
Kimber, J.
Larance, B.
Mattick, R.
Butler, Tony
Degenhardt, L.
A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia
title A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia
title_full A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia
title_fullStr A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia
title_full_unstemmed A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia
title_short A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia
title_sort longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in new south wales, australia
url http://hdl.handle.net/20.500.11937/28267